Xconomy | Boston - Business + Technology in the Exponential Economy

Resolvyx Pharmaceuticals Obtains $17,000,000 Series A Financing

  • Feed Type
  • Date
    12/9/2005
  • Company Name
    Resolvyx Pharmaceuticals
  • Mailing Address
    6A Preston Court Bedford, MA 01730
  • Company Description
    Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body’s own off-switch mechanisms.
  • Website
    http://www.resolvyx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Atlas Venture
  • Venture Investor
    CHL Medical Partners
  • Venture Investor
    Flagship Ventures

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.